MKI67 and breast carcinoma: Montoya et al.’s study based on a single stage III breast cancer patient found that neoadjuvant propranolol reduces pro-proliferative Ki-67 and pro-survival Bcl-2 markers, and significantly increases p53 expression and induces apoptosis [34].